echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > It's sunny and the East Sunshine drug is hitting Merca East 900 million sugar-lowering drugs!

    It's sunny and the East Sunshine drug is hitting Merca East 900 million sugar-lowering drugs!

    • Last Update: 2020-10-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical network October 10, recently, CDE official website shows that Shandong Langno Pharmaceuticals phosphate sigletin imitation 4 categories of listing applications were accepted.
    2019, China's public medical institutions terminal phosphate sigletin tablet sales of more than 900 million yuan, production enterprises only Meshadong.
    in February this year, Zhengda Tianqing Pharmaceuticals was approved for the first time, and in August, Guangdong Dongsian Pharmaceuticals became the second generic drug company to be approved.
    Up to now, the product has Yangzijiang Pharmaceutical Group Guangzhou Hairui Pharmaceuticals, Chenxin Pharmaceuticals, Stone Pharmaceuticals Group, Ouyi Pharmaceuticals and other 10 enterprises to copy 4 categories of submitted listing applications in the review and approval.
    Sigredin phosphate tablets are a powerful, highly selective lipidase-4 (DPP-4) inhibitor, a new oral anti-hyperglycemia drug based on the hormone mechanism of the islet hormone in the intestines to improve blood sugar control in patients with type 2 diabetes.
    In recent years, china's public medical institutions terminal sigletin tablet sales (unit: 100 million yuan) Source: Minet China's public medical institutions terminal competition pattern Mi intranet data show that in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal sigletin tablet sales of more than 900 million yuan, an increase of 34.89 percent year-on-year, production enterprises only in Mosadong.
    source: Mi Net one-click search in February this year, phosphoric acid sigletin tablets are the first to be approved by the pharmaceutical industry, in August, Guangdong Dongsian Pharmaceuticals became the second approved generic pharmaceutical enterprises.
    and both enterprises were approved in the imitation 4 categories, as if through consistency evaluation.
    Source: Minet MED2.0 China Drug Review Database Up to now, the product Yangzijiang Pharmaceutical Group Guangzhou Hairui Pharmaceuticals, ChenXin Pharmaceuticals, Shi Pharmaceutical Group Oyi Pharmaceuticals and other 10 enterprises to copy 4 categories of submitted listing applications in the review and approval.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.